Tricida, Inc. IPO Research Information

Tricida, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Tricida, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Tricida, Inc.	TCDA - NASDAQ	$16.00-$18.00	$19.00	$25.00	11.7 million	6/28/2018
Underwriter(s): Goldman Sachs, J.P. Morgan, Cowen
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2018-06-04 Terms Added 2018-06-18

Tricida, Inc. Quote & Chart - Click for current quote - TCDA

About Tricida, Inc. (adapted from Tricida, Inc. prospectus):
Their goal is to slow the progression of chronic kidney disease, or CKD, through the treatment of metabolic acidosis.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "TCDA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.